Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study.

Maggen C, Dierickx D, Lugtenburg P, Laenen A, Cardonick E, Smakov R, Bellido M, Cabrera-Garcia A, Gziri MM, Halaska MJ, Ottevanger PB, Van Calsteren K, O'Laughlin A, Polushkina E, Van Dam L, Avivi I, Vandenberghe P, Woei-A-Jin FJSH, Amant F; International Network on Cancer, Infertility and Pregnancy.

Lancet Haematol. 2019 Sep 26. pii: S2352-3026(19)30195-4. doi: 10.1016/S2352-3026(19)30195-4. [Epub ahead of print]

PMID:
31564649
2.

Gastric cancer during pregnancy: A report on 13 cases and review of the literature with focus on chemotherapy during pregnancy.

Maggen C, Lok CA, Cardonick E, van Gerwen M, Ottevanger PB, Boere IA, Koskas M, Halaska MJ, Fruscio R, Gziri MM, Witteveen PO, Van Calsteren K, Amant F; International Network on Cancer, Infertility and Pregnancy (INCIP).

Acta Obstet Gynecol Scand. 2019 Sep 16. doi: 10.1111/aogs.13731. [Epub ahead of print]

PMID:
31529466
3.

Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting.

Amant F, Berveiller P, Boere I, Cardonick E, Fruscio R, Fumagalli M, Halaska MJ, Hasenburg A, Johansson ALV, Lambertini M, Lok C, Maggen C, Morice P, Peccatori F, Poortmans P, Van Calsteren K, Vandenbroucke T, van Gerwen M, van den Heuvel-Eibrink M, Zagouri F, Zapardiel I.

Ann Oncol. 2019 Aug 21. pii: mdz228. doi: 10.1093/annonc/mdz228. [Epub ahead of print]

PMID:
31435648
4.

Pregnant women with confirmed neoplasms should not have noninvasive prenatal testing.

Lenaerts L, Van Calsteren K, Che H, Vermeesch JR, Amant F.

Prenat Diagn. 2019 Aug 8. doi: 10.1002/pd.5544. [Epub ahead of print] No abstract available.

PMID:
31393011
5.

Physiologically Based Pharmacokinetic Modeling to Characterize Acetaminophen Pharmacokinetics and N-Acetyl-p-Benzoquinone Imine (NAPQI) Formation in Non-Pregnant and Pregnant Women.

Mian P, van den Anker JN, van Calsteren K, Annaert P, Tibboel D, Pfister M, Allegaert K, Dallmann A.

Clin Pharmacokinet. 2019 Jul 25. doi: 10.1007/s40262-019-00799-5. [Epub ahead of print]

PMID:
31347013
6.

Health products' and substance use among pregnant women visiting a tertiary hospital in Belgium: A cross-sectional study.

Ceulemans M, Van Calsteren K, Allegaert K, Foulon V.

Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1231-1238. doi: 10.1002/pds.4862. Epub 2019 Jul 25.

PMID:
31342605
7.

Long-term impact of prenatal exposure to chemotherapy on executive functioning: An ERP study.

Blommaert J, Zink R, Deprez S, Myatchin I, Dupont P, Vandenbroucke T, Sleurs C, Van Calsteren K, Amant F, Lagae L.

Clin Neurophysiol. 2019 Sep;130(9):1655-1664. doi: 10.1016/j.clinph.2019.06.012. Epub 2019 Jul 9.

PMID:
31330451
8.

Prevalence and characteristics of pregnancy- and lactation-related calls to the National Poison Centre in Belgium: A retrospective analysis of calls from 2012 to 2017.

Ceulemans M, Fortuin M, Van Calsteren K, Allegaert K, Foulon V.

J Eval Clin Pract. 2019 Jul 12. doi: 10.1111/jep.13228. [Epub ahead of print]

PMID:
31298801
9.

Arabic-speaking pregnant women with a migration background: A vulnerable target group for prenatal counseling on medicines.

Ceulemans M, Chaar R, Van Calsteren K, Allegaert K, Foulon V.

Res Social Adm Pharm. 2019 Jun 13. pii: S1551-7411(19)30183-4. doi: 10.1016/j.sapharm.2019.06.004. [Epub ahead of print]

PMID:
31221568
10.

Characteristics of patients with cervical cancer during pregnancy: a multicenter matched cohort study. An initiative from the International Network on Cancer, Infertility and Pregnancy.

Halaska MJ, Uzan C, Han SN, Fruscio R, Dahl Steffensen K, Van Calster B, Stankusova H, Delle Marchette M, Mephon A, Rouzier R, Witteveen PO, Vergani P, Van Calsteren K, Rob L, Amant F.

Int J Gynecol Cancer. 2019 Mar 20. pii: ijgc-2018-000103. doi: 10.1136/ijgc-2018-000103. [Epub ahead of print]

PMID:
30898935
11.

Transplacental transport of paracetamol and its phase II metabolites using the ex vivo placenta perfusion model.

Conings S, Tseke F, Van den Broeck A, Qi B, Paulus J, Amant F, Annaert P, Van Calsteren K.

Toxicol Appl Pharmacol. 2019 May 1;370:14-23. doi: 10.1016/j.taap.2019.03.004. Epub 2019 Mar 5.

PMID:
30849458
12.

Beliefs about medicines and information needs among pregnant women visiting a tertiary hospital in Belgium.

Ceulemans M, Van Calsteren K, Allegaert K, Foulon V.

Eur J Clin Pharmacol. 2019 Jul;75(7):995-1003. doi: 10.1007/s00228-019-02653-w. Epub 2019 Mar 4.

PMID:
30834472
13.

Management of cancer during pregnancy and current evidence of obstetric, neonatal and pediatric outcome: a review article.

Maggen C, van Gerwen M, Van Calsteren K, Vandenbroucke T, Amant F.

Int J Gynecol Cancer. 2019 Jan 18. pii: ijgc-2018-000061. doi: 10.1136/ijgc-2018-000061. [Epub ahead of print]

PMID:
30659032
14.

A rare presentation of homozygous factor X deficiency in a pregnant patient: A case report and review of the literature.

van Dievoet MA, Jacquemin M, Van Calsteren K, Peerlinck K.

Haemophilia. 2019 Jan;25(1):e57-e59. doi: 10.1111/hae.13654. Epub 2018 Dec 3. No abstract available.

PMID:
30507056
15.

Antenatal sildenafil administration to prevent pulmonary hypertension in congenital diaphragmatic hernia (SToP-PH): study protocol for a phase I/IIb placenta transfer and safety study.

Russo FM, Benachi A, Van Mieghem T, De Hoon J, Van Calsteren K, Annaert P, Tréluyer JM, Allegaert K, Deprest J.

Trials. 2018 Sep 27;19(1):524. doi: 10.1186/s13063-018-2897-8.

16.

Sildenafil crosses the placenta at therapeutic levels in a dually perfused human cotyledon model.

Russo FM, Conings S, Allegaert K, Van Mieghem T, Toelen J, Van Calsteren K, Annaert P, Deprest J.

Am J Obstet Gynecol. 2018 Dec;219(6):619.e1-619.e10. doi: 10.1016/j.ajog.2018.08.041. Epub 2018 Sep 5.

PMID:
30194048
17.

Corrigendum to 'Genetic and microscopic assessment of the human chemotherapy-exposed placenta reveals possible pathways contributive to fetal growth restriction'[YPLAC 64C (2018) 61-70].

Verheecke M, Cortès Calabuig A, Finalet Ferreiro J, Brys V, Van Bree R, Verbist G, Everaert T, Leemans L, Gziri MM, Boere I, Halaska MJ, Van Houdt J, Amant F, Van Calsteren K.

Placenta. 2018 Sep;69:117. doi: 10.1016/j.placenta.2018.07.008. Epub 2018 Jul 24. No abstract available.

PMID:
30054016
18.

Genetic and microscopic assessment of the human chemotherapy-exposed placenta reveals possible pathways contributive to fetal growth restriction.

Verheecke M, Cortès Calabuig A, Finalet Ferreiro J, Brys V, Van Bree R, Verbist G, Everaert T, Leemans L, Gziri MM, Boere I, Halaska MJ, Vanhoudt J, Amant F, Van Calsteren K.

Placenta. 2018 Apr;64:61-70. doi: 10.1016/j.placenta.2018.03.002. Epub 2018 Mar 9. Erratum in: Placenta. 2018 Sep;69:117.

PMID:
29626982
19.

Severe Adverse Reaction to Vemurafenib in a Pregnant Woman with Metastatic Melanoma.

de Haan J, van Thienen JV, Casaer M, Hannivoort RA, Van Calsteren K, van Tuyl M, van Gerwen MM, Debeer A, Amant F, Painter RC.

Case Rep Oncol. 2018 Feb 15;11(1):119-124. doi: 10.1159/000487128. eCollection 2018 Jan-Apr.

20.

Renal Neoplasm During Pregnancy: A Single Center Experience.

Chys B, Dumont S, Van Calsteren K, Albersen M, Joniau S.

Clin Genitourin Cancer. 2018 Jun;16(3):e501-e507. doi: 10.1016/j.clgc.2018.02.018. Epub 2018 Feb 23. No abstract available.

PMID:
29566998
21.

Acute Drug Effects on the Human Placental Tissue: The Development of a Placental Murine Xenograft Model.

Verheecke M, Hermans E, Tuyaerts S, Souche E, Van Bree R, Verbist G, Everaert T, Cortès-Calabuig A, Van Houdt J, Van Calsteren K, Amant F.

Reprod Sci. 2018 Dec;25(12):1637-1648. doi: 10.1177/1933719118756771. Epub 2018 Feb 13.

PMID:
29439620
22.

Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients.

de Haan J, Verheecke M, Van Calsteren K, Van Calster B, Shmakov RG, Mhallem Gziri M, Halaska MJ, Fruscio R, Lok CAR, Boere IA, Zola P, Ottevanger PB, de Groot CJM, Peccatori FA, Dahl Steffensen K, Cardonick EH, Polushkina E, Rob L, Ceppi L, Sukhikh GT, Han SN, Amant F; International Network on Cancer and Infertility Pregnancy (INCIP).

Lancet Oncol. 2018 Mar;19(3):337-346. doi: 10.1016/S1470-2045(18)30059-7. Epub 2018 Jan 26.

PMID:
29395867
23.

Pregnancy affects the pharmacokinetics of sildenafil and its metabolite in the rabbit.

Russo FM, Mian P, Krekels EH, Van Calsteren K, Tibboel D, Deprest J, Allegaert K.

Xenobiotica. 2019 Jan;49(1):98-105. doi: 10.1080/00498254.2017.1422217. Epub 2018 Jan 10.

PMID:
29278046
24.

Feasibility of whole-body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study.

Han SN, Amant F, Michielsen K, De Keyzer F, Fieuws S, Van Calsteren K, Dresen RC, Gziri MM, Vandecaveye V.

Eur Radiol. 2018 May;28(5):1862-1874. doi: 10.1007/s00330-017-5126-z. Epub 2017 Dec 7.

PMID:
29218610
25.

Physiological and pathological gestational cardiac hypertrophy: what can we learn from rodents?

Sampaolesi M, Van Calsteren K.

Cardiovasc Res. 2017 Nov 1;113(13):1533-1535. doi: 10.1093/cvr/cvx192. No abstract available.

PMID:
29036549
26.

Maternal and obstetrical outcome in 35 cases of well-differentiated thyroid carcinoma during pregnancy.

Boucek J, de Haan J, Halaska MJ, Plzak J, Van Calsteren K, de Groot CJM, Dahl Steffensen K, Fruscio R, Massolt ET, Klaritsch P, Zola P, Amant F; International Network on Cancer, Infertility, and Pregnancy.

Laryngoscope. 2018 Jun;128(6):1493-1500. doi: 10.1002/lary.26936. Epub 2017 Oct 8.

PMID:
28988434
27.

Comment on "Maternal and perinatal outcomes in pregnancy-associated melanoma. Report of two cases and a systematic literature review".

de Haan J, Van Calsteren K, Lok CAR, de Groot CJM, Amant F.

Eur J Obstet Gynecol Reprod Biol. 2017 Sep;216:261-262. doi: 10.1016/j.ejogrb.2017.07.025. Epub 2017 Jul 23. No abstract available.

PMID:
28768572
28.

Integration and validation of the ex vivo human placenta perfusion model.

Conings S, Amant F, Annaert P, Van Calsteren K.

J Pharmacol Toxicol Methods. 2017 Nov;88(Pt 1):25-31. doi: 10.1016/j.vascn.2017.05.002. Epub 2017 May 15.

PMID:
28522142
29.

Body weight, gender and pregnancy affect enantiomer-specific ketorolac pharmacokinetics.

Välitalo PA, Kemppainen H, Kulo A, Smits A, van Calsteren K, Olkkola KT, de Hoon J, Knibbe CAJ, Allegaert K.

Br J Clin Pharmacol. 2017 Sep;83(9):1966-1975. doi: 10.1111/bcp.13311. Epub 2017 May 14.

30.

Melanoma during pregnancy: a report of 60 pregnancies complicated by melanoma.

de Haan J, Lok CA, de Groot CJ, Crijns MB, Van Calsteren K, Dahl Steffensen K, Halaska MJ, Altintas S, Boere IA, Fruscio R, Kolawa W, Witteveen PO, Amant F; International Network on Cancer, Infertility and Pregnancy (INCIP).

Melanoma Res. 2017 Jun;27(3):218-223. doi: 10.1097/CMR.0000000000000327.

PMID:
28099365
31.

Ovarian cancer in pregnancy.

Fruscio R, de Haan J, Van Calsteren K, Verheecke M, Mhallem M, Amant F.

Best Pract Res Clin Obstet Gynaecol. 2017 May;41:108-117. doi: 10.1016/j.bpobgyn.2016.09.013. Epub 2016 Oct 1. Review.

PMID:
28029502
32.

Enantiomer-specific ketorolac pharmacokinetics in young women, including pregnancy and postpartum period.

Kulo A, Smits A, Maleškić S, Van de Velde M, Van Calsteren K, De Hoon J, Verbesselt R, Deprest J, Allegaert K.

Bosn J Basic Med Sci. 2017 Feb 21;17(1):54-60. doi: 10.17305/bjbms.2016.1515.

33.

Psychological distress and cognitive coping in pregnant women diagnosed with cancer and their partners.

Vandenbroucke T, Han SN, Van Calsteren K, Wilderjans TF, Van den Bergh BRH, Claes L, Amant F.

Psychooncology. 2017 Aug;26(8):1215-1221. doi: 10.1002/pon.4301. Epub 2016 Nov 21. Erratum in: Psychooncology. 2018 Oct;27(10):2521.

PMID:
27859911
34.

Position statement from the European Board and College of Obstetrics & Gynaecology (EBCOG): The use of medicines during pregnancy - call for action.

Van Calsteren K, Gersak K, Sundseth H, Klingmann I, Dewulf L, Van Assche A, Mahmood T.

Eur J Obstet Gynecol Reprod Biol. 2016 Jun;201:189-91. doi: 10.1016/j.ejogrb.2016.04.004. Epub 2016 Apr 9.

PMID:
27132709
35.

Position Statement from the European Board and College of Obstetrics & Gynaecology (EBCOG) : The use of medicines during pregnancy: call for action.

Van Calsteren K, Gersak K, Sundseth H, Klingmann I, Dewulf L, Van Assche A, Mahmood T.

Eur J Obstet Gynecol Reprod Biol. 2016 Jun;201:211-4. doi: 10.1016/j.ejogrb.2016.04.016. Epub 2016 Apr 25. Review.

PMID:
27132708
36.

Effects of prenatal exposure to cancer treatment on neurocognitive development, a review.

Vercruysse DC, Deprez S, Sunaert S, Van Calsteren K, Amant F.

Neurotoxicology. 2016 May;54:11-21. doi: 10.1016/j.neuro.2016.02.013. Epub 2016 Mar 4. Review.

PMID:
26952827
37.

Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy.

Vandenbroucke T, Van Calsteren K, Amant F.

N Engl J Med. 2016 Feb 18;374(7):693. doi: 10.1056/NEJMc1515462. No abstract available.

PMID:
26886537
38.

Hematologic Malignancies in Pregnancy: Management Guidelines From an International Consensus Meeting.

Lishner M, Avivi I, Apperley JF, Dierickx D, Evens AM, Fumagalli M, Nulman I, Oduncu FS, Peccatori FA, Robinson S, Van Calsteren K, Vandenbroucke T, Van den Heuvel F, Amant F.

J Clin Oncol. 2016 Feb 10;34(5):501-8. doi: 10.1200/JCO.2015.62.4445. Epub 2015 Nov 30.

39.

Paracetamol pharmacokinetics and metabolism in young women.

Allegaert K, Peeters MY, Beleyn B, Smits A, Kulo A, van Calsteren K, Deprest J, de Hoon J, Knibbe CA.

BMC Anesthesiol. 2015 Nov 13;15:163. doi: 10.1186/s12871-015-0144-3.

40.

Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy.

Amant F, Vandenbroucke T, Verheecke M, Fumagalli M, Halaska MJ, Boere I, Han S, Gziri MM, Peccatori F, Rob L, Lok C, Witteveen P, Voigt JU, Naulaers G, Vallaeys L, Van den Heuvel F, Lagae L, Mertens L, Claes L, Van Calsteren K; International Network on Cancer, Infertility, and Pregnancy (INCIP).

N Engl J Med. 2015 Nov 5;373(19):1824-34. doi: 10.1056/NEJMoa1508913. Epub 2015 Sep 28.

41.

Breast Cancer Diagnosed During Pregnancy: Adapting Recent Advances in Breast Cancer Care for Pregnant Patients.

Loibl S, Schmidt A, Gentilini O, Kaufman B, Kuhl C, Denkert C, von Minckwitz G, Parokonnaya A, Stensheim H, Thomssen C, van Calsteren K, Poortmans P, Berveiller P, Markert UR, Amant F.

JAMA Oncol. 2015 Nov;1(8):1145-53. doi: 10.1001/jamaoncol.2015.2413. Erratum in: JAMA Oncol. 2015 Nov;1(8):1172.

PMID:
26247818
42.

Spinal subdural haematoma after an epidural blood patch.

Devroe S, Van de Velde M, Demaerel P, Van Calsteren K.

Int J Obstet Anesth. 2015 Aug;24(3):288-9. doi: 10.1016/j.ijoa.2015.05.004. Epub 2015 Jun 3. No abstract available.

PMID:
26116284
43.

Corrigendum to "Semiphysiological versus Empirical Modelling of the Population Pharmacokinetics of Free and Total Cefazolin during Pregnancy".

van Hasselt JG, Allegaert K, van Calsteren K, Beijnen JH, Schellens JH, Huitema AD.

Biomed Res Int. 2015;2015:124035. doi: 10.1155/2015/124035. Epub 2015 Mar 30. No abstract available.

44.

Management of cancer in pregnancy.

Amant F, Han SN, Gziri MM, Vandenbroucke T, Verheecke M, Van Calsteren K.

Best Pract Res Clin Obstet Gynaecol. 2015 Jul;29(5):741-53. doi: 10.1016/j.bpobgyn.2015.02.006. Epub 2015 Mar 4. Review.

PMID:
25797199
45.

Early fetal anatomy screening: who, what, when and why?

Van Mieghem T, Hindryckx A, Van Calsteren K.

Curr Opin Obstet Gynecol. 2015 Apr;27(2):143-50. doi: 10.1097/GCO.0000000000000161. Review.

PMID:
25689240
46.

Fetal outcome after prenatal exposure to chemotherapy and mechanisms of teratogenicity compared to alcohol and smoking.

Vandenbroucke T, Verheecke M, Van Calsteren K, Han S, Claes L, Amant F.

Expert Opin Drug Saf. 2014 Dec;13(12):1653-65. doi: 10.1517/14740338.2014.965677. Epub 2014 Nov 10. Review.

PMID:
25382454
47.

Management of gynecological cancers during pregnancy.

Han SN, Verheecke M, Vandenbroucke T, Gziri MM, Van Calsteren K, Amant F.

Curr Oncol Rep. 2014 Dec;16(12):415. doi: 10.1007/s11912-014-0415-z. Review.

PMID:
25344340
48.

Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel.

van Hasselt JG, van Calsteren K, Heyns L, Han S, Mhallem Gziri M, Schellens JH, Beijnen JH, Huitema AD, Amant F.

Ann Oncol. 2014 Oct;25(10):2059-65. doi: 10.1093/annonc/mdu140. Epub 2014 Apr 8.

PMID:
24713311
49.

Estradiol and weight are covariates of paracetamol clearance in young women.

Beleyn B, Vermeersch S, Kulo A, Smits A, Verbesselt R, de Hoon JN, Van Calsteren K, Allegaert K.

Gynecol Obstet Invest. 2014;77(4):211-6. doi: 10.1159/000358394. Epub 2014 Mar 25.

PMID:
24686129
50.

Semiphysiological versus empirical modelling of the population pharmacokinetics of free and total cefazolin during pregnancy.

van Hasselt JG, Allegaert K, van Calsteren K, Beijnen JH, Schellens JH, Huitema AD.

Biomed Res Int. 2014;2014:897216. doi: 10.1155/2014/897216. Epub 2014 Feb 3. Erratum in: Biomed Res Int. 2015;2015:124035.

Supplemental Content

Loading ...
Support Center